Allergy Research Group – Trademark Portfolio

Entity Type: 16

Allergy Research Group holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 20 filings in this category. Currently, 14 trademarks are registered. Notable registered marks include BUTYREN, OCUDYNE, NATTOZYME, QUELLERGY, and NRF2 RENEW. The owner is based in South Salt Lake, UT.

2300 S. Main Street

South Salt Lake, UT 84115

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Allergy Research Group's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (20 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Allergy Research Group have?

Allergy Research Group has 20 U.S. trademarks filed with the USPTO. Of these, 14 registered, 5 abandoned, 1 cancelled.

What trademark classes does Allergy Research Group file in?

Allergy Research Group files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Allergy Research Group's most well-known trademarks?

Allergy Research Group's registered trademark portfolio includes well-known marks such as BUTYREN, OCUDYNE, NATTOZYME, QUELLERGY, and NRF2 RENEW. These are among 14 currently registered trademarks in the portfolio.

What is Allergy Research Group's trademark registration success rate?

Allergy Research Group has a 70% trademark registration rate, with 14 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.